nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—TPO—Thyroxine (Thyroid Hormone) Production—TG—thyroid cancer	0.285	0.412	CbGpPWpGaD
Carbimazole—TPO—Thyroxine (Thyroid Hormone) Production—TSHR—thyroid cancer	0.115	0.167	CbGpPWpGaD
Carbimazole—TPO—Thyroxine (Thyroid Hormone) Production—SLC5A5—thyroid cancer	0.0864	0.125	CbGpPWpGaD
Carbimazole—TPO—Thyroxine biosynthesis—SLC5A5—thyroid cancer	0.0686	0.099	CbGpPWpGaD
Carbimazole—TPO—Amine-derived hormones—SLC5A5—thyroid cancer	0.0394	0.0569	CbGpPWpGaD
Carbimazole—TPO—neck—thyroid cancer	0.0309	0.551	CbGeAlD
Carbimazole—TPO—Hematopoietic Stem Cell Differentiation—EPO—thyroid cancer	0.0198	0.0286	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—EPO—thyroid cancer	0.0172	0.0248	CbGpPWpGaD
Carbimazole—TPO—thyroid gland—thyroid cancer	0.0147	0.262	CbGeAlD
Carbimazole—Oropharyngeal discomfort—Sorafenib—thyroid cancer	0.00964	0.0384	CcSEcCtD
Carbimazole—CYP19A1—Endogenous sterols—RXRA—thyroid cancer	0.00755	0.0109	CbGpPWpGaD
Carbimazole—Mouth ulceration—Sorafenib—thyroid cancer	0.00634	0.0252	CcSEcCtD
Carbimazole—Neutropenia—Vandetanib—thyroid cancer	0.0061	0.0243	CcSEcCtD
Carbimazole—Stomatitis—Vandetanib—thyroid cancer	0.00566	0.0225	CcSEcCtD
Carbimazole—TPO—Amino acid and derivative metabolism—SLC5A5—thyroid cancer	0.00549	0.00792	CbGpPWpGaD
Carbimazole—Haemoglobin—Vandetanib—thyroid cancer	0.00524	0.0209	CcSEcCtD
Carbimazole—Haemorrhage—Vandetanib—thyroid cancer	0.00522	0.0208	CcSEcCtD
Carbimazole—CYP19A1—Metapathway biotransformation—CHST14—thyroid cancer	0.00511	0.00738	CbGpPWpGaD
Carbimazole—Angiopathy—Vandetanib—thyroid cancer	0.00473	0.0188	CcSEcCtD
Carbimazole—Alopecia—Vandetanib—thyroid cancer	0.00461	0.0184	CcSEcCtD
Carbimazole—CYP19A1—thyroid gland—thyroid cancer	0.00419	0.0747	CbGeAlD
Carbimazole—Neutropenia—Sorafenib—thyroid cancer	0.00411	0.0164	CcSEcCtD
Carbimazole—Arthralgia—Vandetanib—thyroid cancer	0.00387	0.0154	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00384	0.0153	CcSEcCtD
Carbimazole—Bone marrow depression—Epirubicin—thyroid cancer	0.00384	0.0153	CcSEcCtD
Carbimazole—Jaundice—Sorafenib—thyroid cancer	0.00382	0.0152	CcSEcCtD
Carbimazole—Stomatitis—Sorafenib—thyroid cancer	0.00382	0.0152	CcSEcCtD
Carbimazole—CYP19A1—head—thyroid cancer	0.00372	0.0663	CbGeAlD
Carbimazole—Infection—Vandetanib—thyroid cancer	0.00368	0.0147	CcSEcCtD
Carbimazole—TPO—Metabolism—MINPP1—thyroid cancer	0.00364	0.00525	CbGpPWpGaD
Carbimazole—Nervous system disorder—Vandetanib—thyroid cancer	0.00363	0.0145	CcSEcCtD
Carbimazole—Thrombocytopenia—Vandetanib—thyroid cancer	0.00363	0.0144	CcSEcCtD
Carbimazole—Skin disorder—Vandetanib—thyroid cancer	0.0036	0.0143	CcSEcCtD
Carbimazole—Bone marrow depression—Doxorubicin—thyroid cancer	0.00355	0.0141	CcSEcCtD
Carbimazole—Haemoglobin—Sorafenib—thyroid cancer	0.00354	0.0141	CcSEcCtD
Carbimazole—Haemorrhage—Sorafenib—thyroid cancer	0.00352	0.014	CcSEcCtD
Carbimazole—CYP19A1—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.0035	0.00506	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00338	0.0134	CcSEcCtD
Carbimazole—Ageusia—Epirubicin—thyroid cancer	0.0032	0.0127	CcSEcCtD
Carbimazole—Angiopathy—Sorafenib—thyroid cancer	0.00319	0.0127	CcSEcCtD
Carbimazole—Alopecia—Sorafenib—thyroid cancer	0.00311	0.0124	CcSEcCtD
Carbimazole—TPO—Metabolism—NDUFA13—thyroid cancer	0.00309	0.00447	CbGpPWpGaD
Carbimazole—Ageusia—Doxorubicin—thyroid cancer	0.00296	0.0118	CcSEcCtD
Carbimazole—Jaundice cholestatic—Epirubicin—thyroid cancer	0.00295	0.0117	CcSEcCtD
Carbimazole—Body temperature increased—Vandetanib—thyroid cancer	0.00293	0.0117	CcSEcCtD
Carbimazole—TPO—Metabolism—CHST14—thyroid cancer	0.00291	0.0042	CbGpPWpGaD
Carbimazole—CYP19A1—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00284	0.0041	CbGpPWpGaD
Carbimazole—Angioedema—Sorafenib—thyroid cancer	0.0028	0.0111	CcSEcCtD
Carbimazole—Leukopenia—Sorafenib—thyroid cancer	0.00274	0.0109	CcSEcCtD
Carbimazole—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.00273	0.0109	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TPR—thyroid cancer	0.00266	0.00384	CbGpPWpGaD
Carbimazole—Pruritus—Vandetanib—thyroid cancer	0.00262	0.0104	CcSEcCtD
Carbimazole—Arthralgia—Sorafenib—thyroid cancer	0.00261	0.0104	CcSEcCtD
Carbimazole—Myalgia—Sorafenib—thyroid cancer	0.00261	0.0104	CcSEcCtD
Carbimazole—CYP19A1—lymph node—thyroid cancer	0.0026	0.0464	CbGeAlD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00259	0.0103	CcSEcCtD
Carbimazole—Hepatocellular injury—Epirubicin—thyroid cancer	0.00259	0.0103	CcSEcCtD
Carbimazole—Infection—Sorafenib—thyroid cancer	0.00248	0.00989	CcSEcCtD
Carbimazole—Nervous system disorder—Sorafenib—thyroid cancer	0.00245	0.00976	CcSEcCtD
Carbimazole—Thrombocytopenia—Sorafenib—thyroid cancer	0.00245	0.00974	CcSEcCtD
Carbimazole—Aplastic anaemia—Epirubicin—thyroid cancer	0.00243	0.00968	CcSEcCtD
Carbimazole—Skin disorder—Sorafenib—thyroid cancer	0.00243	0.00967	CcSEcCtD
Carbimazole—Hepatocellular injury—Doxorubicin—thyroid cancer	0.0024	0.00954	CcSEcCtD
Carbimazole—TPO—Metabolism—HPGD—thyroid cancer	0.00234	0.00338	CbGpPWpGaD
Carbimazole—Mouth ulceration—Epirubicin—thyroid cancer	0.00234	0.00932	CcSEcCtD
Carbimazole—Rash—Vandetanib—thyroid cancer	0.00234	0.0093	CcSEcCtD
Carbimazole—Dermatitis—Vandetanib—thyroid cancer	0.00233	0.00929	CcSEcCtD
Carbimazole—Headache—Vandetanib—thyroid cancer	0.00232	0.00924	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00228	0.00907	CcSEcCtD
Carbimazole—Aplastic anaemia—Doxorubicin—thyroid cancer	0.00225	0.00896	CcSEcCtD
Carbimazole—Nausea—Vandetanib—thyroid cancer	0.0022	0.00876	CcSEcCtD
Carbimazole—Mouth ulceration—Doxorubicin—thyroid cancer	0.00217	0.00862	CcSEcCtD
Carbimazole—Urticaria—Sorafenib—thyroid cancer	0.00199	0.00791	CcSEcCtD
Carbimazole—Body temperature increased—Sorafenib—thyroid cancer	0.00198	0.00787	CcSEcCtD
Carbimazole—Hypersensitivity—Sorafenib—thyroid cancer	0.00184	0.00733	CcSEcCtD
Carbimazole—Pruritus—Sorafenib—thyroid cancer	0.00177	0.00704	CcSEcCtD
Carbimazole—Liver function test abnormal—Epirubicin—thyroid cancer	0.00174	0.00691	CcSEcCtD
Carbimazole—CYP19A1—FSH signaling pathway—AKT1—thyroid cancer	0.00166	0.00239	CbGpPWpGaD
Carbimazole—Eosinophilia—Epirubicin—thyroid cancer	0.00161	0.0064	CcSEcCtD
Carbimazole—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00161	0.00639	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.0016	0.00232	CbGpPWpGaD
Carbimazole—Rash—Sorafenib—thyroid cancer	0.00158	0.00628	CcSEcCtD
Carbimazole—Dermatitis—Sorafenib—thyroid cancer	0.00158	0.00627	CcSEcCtD
Carbimazole—Headache—Sorafenib—thyroid cancer	0.00157	0.00623	CcSEcCtD
Carbimazole—Pancytopenia—Epirubicin—thyroid cancer	0.00154	0.00614	CcSEcCtD
Carbimazole—Neutropenia—Epirubicin—thyroid cancer	0.00152	0.00605	CcSEcCtD
Carbimazole—CYP19A1—Biological oxidations—RXRA—thyroid cancer	0.00151	0.00218	CbGpPWpGaD
Carbimazole—Eosinophilia—Doxorubicin—thyroid cancer	0.00149	0.00593	CcSEcCtD
Carbimazole—Nausea—Sorafenib—thyroid cancer	0.00149	0.00591	CcSEcCtD
Carbimazole—Pancytopenia—Doxorubicin—thyroid cancer	0.00143	0.00568	CcSEcCtD
Carbimazole—Stomatitis—Epirubicin—thyroid cancer	0.00141	0.00562	CcSEcCtD
Carbimazole—Jaundice—Epirubicin—thyroid cancer	0.00141	0.00562	CcSEcCtD
Carbimazole—Neutropenia—Doxorubicin—thyroid cancer	0.00141	0.0056	CcSEcCtD
Carbimazole—Agranulocytosis—Epirubicin—thyroid cancer	0.00135	0.00538	CcSEcCtD
Carbimazole—TPO—Metabolism—TPR—thyroid cancer	0.00135	0.00194	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PRKAR1A—thyroid cancer	0.00132	0.00191	CbGpPWpGaD
Carbimazole—Haemoglobin—Epirubicin—thyroid cancer	0.00131	0.0052	CcSEcCtD
Carbimazole—Stomatitis—Doxorubicin—thyroid cancer	0.00131	0.0052	CcSEcCtD
Carbimazole—Jaundice—Doxorubicin—thyroid cancer	0.00131	0.0052	CcSEcCtD
Carbimazole—Haemorrhage—Epirubicin—thyroid cancer	0.0013	0.00518	CcSEcCtD
Carbimazole—Hepatitis—Epirubicin—thyroid cancer	0.0013	0.00518	CcSEcCtD
Carbimazole—Agranulocytosis—Doxorubicin—thyroid cancer	0.00125	0.00498	CcSEcCtD
Carbimazole—Haemoglobin—Doxorubicin—thyroid cancer	0.00121	0.00481	CcSEcCtD
Carbimazole—Hepatitis—Doxorubicin—thyroid cancer	0.0012	0.00479	CcSEcCtD
Carbimazole—Haemorrhage—Doxorubicin—thyroid cancer	0.0012	0.00479	CcSEcCtD
Carbimazole—Angiopathy—Epirubicin—thyroid cancer	0.00118	0.0047	CcSEcCtD
Carbimazole—Alopecia—Epirubicin—thyroid cancer	0.00115	0.00457	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—MINPP1—thyroid cancer	0.00111	0.0016	CbGpPWpGaD
Carbimazole—Angiopathy—Doxorubicin—thyroid cancer	0.00109	0.00435	CcSEcCtD
Carbimazole—Alopecia—Doxorubicin—thyroid cancer	0.00106	0.00423	CcSEcCtD
Carbimazole—Ill-defined disorder—Epirubicin—thyroid cancer	0.00105	0.00418	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.00103	0.00149	CbGpPWpGaD
Carbimazole—Malaise—Epirubicin—thyroid cancer	0.00102	0.00406	CcSEcCtD
Carbimazole—Leukopenia—Epirubicin—thyroid cancer	0.00101	0.00403	CcSEcCtD
Carbimazole—TPO—Metabolism—SLC5A5—thyroid cancer	0.00101	0.00146	CbGpPWpGaD
Carbimazole—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000972	0.00387	CcSEcCtD
Carbimazole—Arthralgia—Epirubicin—thyroid cancer	0.000964	0.00384	CcSEcCtD
Carbimazole—Myalgia—Epirubicin—thyroid cancer	0.000964	0.00384	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000957	0.00381	CcSEcCtD
Carbimazole—Discomfort—Epirubicin—thyroid cancer	0.000952	0.00379	CcSEcCtD
Carbimazole—Malaise—Doxorubicin—thyroid cancer	0.000945	0.00376	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—NDUFA13—thyroid cancer	0.000943	0.00136	CbGpPWpGaD
Carbimazole—Leukopenia—Doxorubicin—thyroid cancer	0.000938	0.00373	CcSEcCtD
Carbimazole—Infection—Epirubicin—thyroid cancer	0.000918	0.00365	CcSEcCtD
Carbimazole—Nervous system disorder—Epirubicin—thyroid cancer	0.000906	0.00361	CcSEcCtD
Carbimazole—Thrombocytopenia—Epirubicin—thyroid cancer	0.000905	0.0036	CcSEcCtD
Carbimazole—Skin disorder—Epirubicin—thyroid cancer	0.000898	0.00357	CcSEcCtD
Carbimazole—Arthralgia—Doxorubicin—thyroid cancer	0.000892	0.00355	CcSEcCtD
Carbimazole—Myalgia—Doxorubicin—thyroid cancer	0.000892	0.00355	CcSEcCtD
Carbimazole—CYP19A1—Metabolism—CHST14—thyroid cancer	0.000886	0.00128	CbGpPWpGaD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000886	0.00353	CcSEcCtD
Carbimazole—Discomfort—Doxorubicin—thyroid cancer	0.000881	0.00351	CcSEcCtD
Carbimazole—Infection—Doxorubicin—thyroid cancer	0.000849	0.00338	CcSEcCtD
Carbimazole—TPO—Metabolism—RXRA—thyroid cancer	0.000847	0.00122	CbGpPWpGaD
Carbimazole—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000842	0.00335	CcSEcCtD
Carbimazole—Nervous system disorder—Doxorubicin—thyroid cancer	0.000838	0.00334	CcSEcCtD
Carbimazole—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000837	0.00333	CcSEcCtD
Carbimazole—Skin disorder—Doxorubicin—thyroid cancer	0.00083	0.00331	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000779	0.0031	CcSEcCtD
Carbimazole—Feeling abnormal—Epirubicin—thyroid cancer	0.000761	0.00303	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.000752	0.00109	CbGpPWpGaD
Carbimazole—Urticaria—Epirubicin—thyroid cancer	0.000734	0.00292	CcSEcCtD
Carbimazole—Body temperature increased—Epirubicin—thyroid cancer	0.00073	0.00291	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.000725	0.00105	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—HPGD—thyroid cancer	0.000714	0.00103	CbGpPWpGaD
Carbimazole—Feeling abnormal—Doxorubicin—thyroid cancer	0.000705	0.0028	CcSEcCtD
Carbimazole—Hypersensitivity—Epirubicin—thyroid cancer	0.000681	0.00271	CcSEcCtD
Carbimazole—Urticaria—Doxorubicin—thyroid cancer	0.000679	0.0027	CcSEcCtD
Carbimazole—Body temperature increased—Doxorubicin—thyroid cancer	0.000676	0.00269	CcSEcCtD
Carbimazole—Pruritus—Epirubicin—thyroid cancer	0.000654	0.0026	CcSEcCtD
Carbimazole—Hypersensitivity—Doxorubicin—thyroid cancer	0.00063	0.00251	CcSEcCtD
Carbimazole—Pruritus—Doxorubicin—thyroid cancer	0.000605	0.00241	CcSEcCtD
Carbimazole—Rash—Epirubicin—thyroid cancer	0.000583	0.00232	CcSEcCtD
Carbimazole—Dermatitis—Epirubicin—thyroid cancer	0.000582	0.00232	CcSEcCtD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.00058	0.000837	CbGpPWpGaD
Carbimazole—Headache—Epirubicin—thyroid cancer	0.000579	0.0023	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.000557	0.000804	CbGpPWpGaD
Carbimazole—Nausea—Epirubicin—thyroid cancer	0.000549	0.00218	CcSEcCtD
Carbimazole—Rash—Doxorubicin—thyroid cancer	0.000539	0.00215	CcSEcCtD
Carbimazole—Dermatitis—Doxorubicin—thyroid cancer	0.000539	0.00214	CcSEcCtD
Carbimazole—Headache—Doxorubicin—thyroid cancer	0.000536	0.00213	CcSEcCtD
Carbimazole—TPO—Metabolism—PPARG—thyroid cancer	0.000535	0.000772	CbGpPWpGaD
Carbimazole—Nausea—Doxorubicin—thyroid cancer	0.000508	0.00202	CcSEcCtD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.000495	0.000715	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTGS2—thyroid cancer	0.000421	0.000607	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	0.000418	0.000604	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—TPR—thyroid cancer	0.00041	0.000592	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PRKAR1A—thyroid cancer	0.000404	0.000583	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTEN—thyroid cancer	0.000367	0.00053	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	0.000366	0.000528	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SLC5A5—thyroid cancer	0.000307	0.000443	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	0.000288	0.000416	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—RXRA—thyroid cancer	0.000258	0.000373	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	0.000251	0.000362	CbGpPWpGaD
Carbimazole—TPO—Metabolism—AKT1—thyroid cancer	0.000211	0.000305	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PPARG—thyroid cancer	0.000163	0.000235	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTGS2—thyroid cancer	0.000128	0.000185	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTEN—thyroid cancer	0.000112	0.000161	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—AKT1—thyroid cancer	6.44e-05	9.3e-05	CbGpPWpGaD
